An improved process for preparing Nhydroxy-4-{5- [4- (5-isopropyl-2-methyl-l, 3-thiazol-4-yl) - phenoxy] -pentoxy }-benzamidine
Details for Australian Patent Application No. 2005260326 (hide)
International Classifications
Event Publications
1 February 2007 PCT application entered the National Phase
PCT publication WO2006/004368 Priority application(s): WO2006/004368
23 October 2008 Application Accepted
Published as AU-B-2005260326
19 February 2009 Standard Patent Sealed
3 September 2009 Amendment Made
The nature of the amendment is: Amend the patentee name to Dong Wha Pharmaceutical Co., Ltd.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005260327-Pharmaceutical composition for the treatment of bone fracture
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser